SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 86.65 |
Enterprise Value ($M) | 84.12 |
Book Value ($M) | -7.98 |
Book Value / Share | -0.14 |
Price / Book | -10.86 |
NCAV ($M) | -11.02 |
NCAV / Share | -0.20 |
Price / NCAV | -7.86 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -1.28 |
Return on Equity (ROE) | -2.84 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.23 |
Current Ratio | 0.23 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3.17 |
Assets | 6.22 |
Liabilities | 14.20 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -37.87 |
Net Income | -37.34 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -31.41 |
Cash from Investing | -5.50 |
Cash from Financing | 22.32 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Highbridge Capital Management Llc | 6.50 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
258,949 | 1,394,208 | 18.57 | |
674,119 | 194,433 | 346.71 | |
433,856 | 273,249 | 158.78 | |
141,609 | 563,827 | 25.12 | |
(click for more detail) |
Similar Companies | |
---|---|
SEEL – Seelos Therapeutics, Inc. | SHPH – Shuttle Pharmaceuticals Holdings, Inc. |
SLRX – Salarius Pharmaceuticals, Inc. | SMFL – Smart for Life, Inc. |
SNDL – SNDL Inc. |
Financial data and stock pages provided by
Fintel.io